Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Brusch

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Infectious Disease Clinics of North America|July 13, 2001
Cardiac infections in the immunosuppressed patientJ L Brusch
The Medical Clinics of North America|September 1, 1988
Fever of unknown originJ L Brusch, L Weinstein
JAMA|September 27, 1976
Positive differential heterophile antibody test. Persistence in a symptomatic patientC Askinazi, F S Cole, J L Brusch
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|June 1, 1979
A circulating anticoagulant in lepromatous leprosyF S Cole, J L Brusch, L Talarico
Antimicrobial Agents and Chemotherapy|October 1, 1973
Bactericidal activity and pharmacology of cefazolinM G Bergeron, J L Brusch, M Barza, et al.
The American Journal of the Medical Sciences|January 1, 1974
An in vitro and pharmacological comparison of amoxicillin and ampicillinJ L Brusch, M G Bergeron, M Barza, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1976
Significant reduction in the incidence of phlebitis with buffered versus unbuffered cephalothinM G Bergeron, J L Brusch, M Barza, et al.
The American Journal of the Medical Sciences|January 1, 1976
Bactericidal activity and pharmacology of flucloxacillinM G Bergeron, J L Brusch, M Barza, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1972
Cross-resistance of Pseudomonas to gentamicin and tobramycinJ L Brusch, M Barza, M G Bergeron, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1975
Effect of probenecid on penetration of oxacillin into fibrin clots in vitroR D Lee, J L Brusch, M J Barza, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Infectious Disease Clinics of North America|July 13, 2001
Cardiac infections in the immunosuppressed patientJ L Brusch
The Medical Clinics of North America|September 1, 1988
Fever of unknown originJ L Brusch, L Weinstein
JAMA|September 27, 1976
Positive differential heterophile antibody test. Persistence in a symptomatic patientC Askinazi, F S Cole, J L Brusch
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|June 1, 1979
A circulating anticoagulant in lepromatous leprosyF S Cole, J L Brusch, L Talarico
Antimicrobial Agents and Chemotherapy|October 1, 1973
Bactericidal activity and pharmacology of cefazolinM G Bergeron, J L Brusch, M Barza, et al.
The American Journal of the Medical Sciences|January 1, 1974
An in vitro and pharmacological comparison of amoxicillin and ampicillinJ L Brusch, M G Bergeron, M Barza, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1976
Significant reduction in the incidence of phlebitis with buffered versus unbuffered cephalothinM G Bergeron, J L Brusch, M Barza, et al.
The American Journal of the Medical Sciences|January 1, 1976
Bactericidal activity and pharmacology of flucloxacillinM G Bergeron, J L Brusch, M Barza, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1972
Cross-resistance of Pseudomonas to gentamicin and tobramycinJ L Brusch, M Barza, M G Bergeron, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1975
Effect of probenecid on penetration of oxacillin into fibrin clots in vitroR D Lee, J L Brusch, M J Barza, et al.
Pageof 2